Stock Taper
SCREENER COMPARE ANY 2 STOCKS
SLXNW
SILEXION THERAPEUTICS LTD.
NASDAQ
$0.01
▼ DOWN 11.43% (0.00)

KEY STATISTICS

Market Cap$7.85 K
52w High$0.03
52w Low$0.01
Dividend Yield—
Frequency—
P/E—
Volume3.05K
Shares Out.560.96K

COMPANY

LEADERSHIP

Ilan Hadar
CHIEF EXECUTIVE
Ilan Hadar

COMPENSATION 2026

Salary$240,560
Stock Awards$1,192,785
Incentive Plan Pay$0
All Other Comp.$107,283
Total$1,540,628

ABOUT

SECTOR
Healthcare
WENT PUBLIC
August 16, 2024
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
14

UPCOMING EARNINGS

DateNov 18, 2026
DayWednesday
Rev. Est.—
NOV
18
WED

PRICE

$0.01 ▼ DOWN 11.43% (−$0.00)
$0.01$0.01$0.01$0.01$0.02$0.021:52 PM2:12 PM2:31 PM2:51 PM3:11 PM3:30 PM3:50 PM0.01

About Silexion Therapeutics Ltd.

https://silexion.com ↗

Silexion Therapeutics LTD develops RNAi-based cancer therapies using its proprietary LODER delivery platform for solid tumors, with products in various pre-clinical and clinical stages targeting pancreatic, prostate, and brain cancers.

INDUSTRY

Biotechnology

A PRODUCT SILEXION THERAPEUTICS LTD. IS KNOWN FOR

SIL-204
SIL-204

SIL-204 is a clinical-stage, RNAi-based therapy targeting KRAS-driven cancers, initially focusing on pancreatic cancer, delivered directly into tumors for localized, extended-release treatment.

COMPETITORS

COMPETITOR
ALNY COMPARE
ARWR COMPARE
IONS COMPARE
ONCY COMPARE
RVMD COMPARE

INSTITUTIONAL OWNERSHIP

SHARES OWNED
100.00%
HOLDERS
26
TOP 12 OF 26 · RANKED BY POSITION SIZE
Polar Asset Management Partners Inc.
743.5K sh · $15.91K
Linden Advisors LP
337.5K sh · $7.22K
Aristeia Capital LLC
236.5K sh · $6.29K
Susquehanna International Group, Llp
220.1K sh · $7.75K
Clear Street LLC
219.8K sh · $8.99K
Clear Street Group Inc.
219.6K sh · $7.73K
Security Benefit Life Insurance Co /Ks/
150.0K sh · $1.88K
Goldman Sachs Group Inc
123.5K sh · $2.51K
Kepos Capital LP
100.0K sh · $2K
Jane Street Group, LLC
74.9K sh · $1.52K
Picton Mahoney Asset Management
57.2K sh · $1.16K
Context Capital Management, LLC
51.2K sh · $1.04K

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book5
Overall Score2

INSIDER TRADES

★
OFFICER: CFO AND SECRETARY
Horenshtein Hadar Mirit
Purchase · 7.5K shares
2026-06-04
★
DIRECTOR, OFFICER: CHAIRMAN AND CEO
Hadar Ilan
Purchase · 10.0K shares
2026-06-04
★
OFFICER: CSO AND CDO
Shirvan Mitchell
Purchase · 6.0K shares
2026-06-04
★
OFFICER: CSO AND CDO
Shirvan Mitchell
Sale · 22.8K shares
2026-03-26

SECTORS PEERS

PEERPRICE
PIII$9.22COMPARE
AKTX$10.70COMPARE
REVB$1.05COMPARE
ACON$2.40COMPARE
DRMA$1.34COMPARE
PPBT$1.68COMPARE
VINC$0.01COMPARE
SYRS$0.00COMPARE